British Journal of Cancer

FIGURE 3

FROM:

Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer

K Talvinen, J Tuikkala, O Nevalainen, A Rantanen, P Hirsimäki, J Sundström and P Kronqvist

BACK TO ARTICLE

Figure 3.

Figure and tables index
Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Kaplan–Meier curves of securin immunohistochemistry distinguish patients with low (<10% securin immunopositivity), intermediate (10–20% securin immunopositivity) and high (>20% securin immunopositivity) risk of death due to breast cancer (n=44) (P=0.0112).

Figure and tables index
BACK TO ARTICLE